Overview
Product name | Recombinant Human Follistatin-like protein 1/FSTL1 Protein |
---|
Catalog No. | RP03228 |
---|
Description | Recombinant Human Follistatin-like protein 1/FSTL1 Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Glu21-Ile308) of Human Follistatin-like protein 1/FSTL1 (Accession #NP_009016.1) fused with a His t |
---|
Purity | PBS |
---|
Endotoxin | <0.01 EU/μg |
---|
Formulation | Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
---|
Species | Human |
---|
Calculated MW | 33.52 kDa |
---|
Background
Follistatin-like 1 (FSTL1), a secreted glycoprotein, has been shown to participate in regulating developmental processes and to be involved in states of disease and injury. Recent findings on FSTL1 in both acute coronary syndrome and heart failure emphasize its potential as a target for cardiac regenerative therapy.
Product information
Synonym | FSTL1; FRP; Follistatin-related protein 1; Follistatin-like protein 1 |
---|
Expression Host | HEK293 cells |
---|
Tag | C-6*His |
---|
Swiss-Prot | |
---|
Gene ID | |
---|
Usage guide
Storage | Store at -20℃.Store the lyophilized protein at -20℃ to -80 ℃ up to 1 year from the date of receipt. After reconstitution, the protein solution is stable at -20℃ for 3 months, at 2-8℃ for up to 1 week. |
---|
Reconstitution | Centrifuge the vial before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid vortex or vigorously pipetting the protein. For long term storage, it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose), and aliquot the reconstituted protein solution to minimize free-thaw cycles. |
---|
* For research use only. Not for therapeutic or diagnostic purposes.